{"nctId":"NCT03936387","briefTitle":"Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study","startDateStruct":{"date":"2019-07-01","type":"ACTUAL"},"conditions":["Pain, Postoperative"],"count":10,"armGroups":[{"label":"Bilateral erector spinae blocks","type":"EXPERIMENTAL","interventionNames":["Drug: Ropivacaine"]}],"interventions":[{"name":"Ropivacaine","otherNames":["Naropin"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Scheduled as part of the cardiac surgical ERAS program.\n2. Scheduled for a primary sternotomy.\n3. Ages 3-21 years.\n\nExclusion Criteria:\n\n1. Patients undergoing reoperative procedures.\n2. Significant scoliosis or other anatomic contraindications to ESB.\n3. History of bleeding or current therapeutic dose anticoagulant use.\n4. Significant intraoperative hemodynamic instability or bleeding, as ascertained by clinicians taking care of the patient.\n5. Patients with severe neurodevelopmental delays.\n6. Patients with previous chronic pain syndromes.\n7. Patients with a history of opioid treatment at any point in the 2 months prior to surgery.\n8. Lack of parental consent and/or child assent.","healthyVolunteers":true,"sex":"ALL","minimumAge":"3 Years","maximumAge":"21 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Who Completed a Successful Intervention With No Major Adverse Events","description":"For this study, 'feasibility' will be defined primarily as a successful intervention completion rate of 75% or greater of all subjects with no major adverse outcomes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Completed a Successful Intervention With a Full Data Set","description":"Secondary measures of feasibility will include aggregate 'data integrity' as defined by successful collection of 75% or greater of all possible data points for successfully completed subjects as well as 'efficient intervention duration' as evaluated by intervention completion time being less than 40 minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":[]}}}